John Mok

Forum Replies Created

Viewing 4 posts - 1 through 4 (of 4 total)
  • Author
    Posts
  • in reply to: version formatting #16523

    John Mok
    Participant

    A specific question about LOINC’s copyright notice and license, if there is anything change in the terms of use, in what way we can recognize the change?
    Thanks for any comment and information!

    in reply to: LOINC Implementation Helpful Suggestions #16557

    John Mok
    Participant

    Hi,

    May I know is there any mapping guidelines, QA or troubleshooting checklist for a LOINC implementator to check the mapping from others who mapped their lab test codes with LOINC?

    Any kind of help is appreciated.

    Regards,
    John Mok

    in reply to: Test display name for EHR #16629

    John Mok
    Participant

    Thanks. I’ll send you a email to seek your help and make reference to your institution’s test catalog and policy. Tks!

    in reply to: Cellular Immunology Tests (Control serum) #16593

    John Mok
    Participant

    Attached with a sample report:-

    NK CELL NUMBER & FUNCTION

    Specimen: Heparinised and EDTA blood

    PATIENT CONTROL NORMAL RANGE(For age)
    WBC 7060 /uL 4790 /uL 4500 – 8400
    Differential N(25) L(65) M(5) E(1) N(48) L(37) M(7) E(3)
    B(1) O(3) B(1) O(4)
    Lymphocytes 4582 H /uL 1782 /uL 1500 – 3200
    NK cells (CD3-CD16/56+) % 2.0 L % 12.2 % 11 – 24
    NK cells (CD3-CD16/56+) no. 93 L /uL 217 /uL 300 – 600

    MICROCYTOTOXICITY ASSAY
    Target cell : Effector cell NORMAL RANGE(Adult)
    1 : 5 0.7 L % 13.3 % 1 – 43
    1 : 10 4.6 % 21.0 % 2 – 68
    1 : 20 10.4 L % 36.6 % 15 – 78
    1 : 40 16.1 L % 48.9 % 23 – 77
    1 : 80 21.6 L % 53.9 % 27 – 80

    Comment: Low NK cytotoxicity partly due to low NK cell number. Taking this into
    consideration the NK cytotoxicity is considered impaired or low normal.

Viewing 4 posts - 1 through 4 (of 4 total)